Detalhe da pesquisa
1.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
2.
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Haematologica
; 105(2): 366-374, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018976
3.
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.
Blood
; 129(3): 371-382, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856463
4.
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis.
Clin Chem
; 64(3): 547-555, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29237714
5.
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
Blood
; 126(26): 2832-41, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486787
6.
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
Blood
; 123(25): 3951-62, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24778155
7.
CD52 is a molecular target in advanced systemic mastocytosis.
FASEB J
; 28(8): 3540-51, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24760752
8.
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.
Blood
; 117(12): 3409-20, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220747
9.
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib.
Blood
; 118(7): 1885-98, 2011 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21680801
10.
Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
FASEB J
; 26(2): 894-906, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22051730
11.
Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.
Am J Pathol
; 178(5): 2344-56, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21457934
12.
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs.
Blood
; 114(26): 5342-51, 2009 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19850739
13.
Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion.
Mol Cancer
; 9: 200, 2010 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20667089
14.
Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.
Am J Pathol
; 175(6): 2416-29, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19893034
15.
A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.
Front Pediatr
; 8: 52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154197
16.
Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.
Exp Hematol
; 36(11): 1461-70, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723263
17.
Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.
Exp Hematol
; 35(10): 1510-21, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17681669
18.
Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.
Haematologica
; 92(11): 1451-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18024392
19.
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
Leuk Lymphoma
; 48(10): 1997-2007, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17917967
20.
Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells.
Vet Immunol Immunopathol
; 115(3-4): 320-33, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17196258